Early Postoperative Cognitive Impairment in Elderly Patients Following Ocular Surgery

Sponsor
Medical University of Vienna (Other)
Overall Status
Recruiting
CT.gov ID
NCT03775343
Collaborator
(none)
75
1
49.8
1.5

Study Details

Study Description

Brief Summary

This project will investigate changes in cognitive function in the early postoperative phase (<24 hours) after minor surgery in patients of older age (≥65 years).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Neurocognitive Test Battery
  • Diagnostic Test: Blood sampling

Detailed Description

Primary aim of this study is to evaluate changes in cognitive function in the early postoperative phase after minor surgery in patients of older age (≥65 years).

Background: Postoperative cognitive dysfunction can be a serious complication after surgery and is associated with higher mortality.Several studies have demonstrated that major surgery and patients of older age are risk factors for the incidence of cognitive decline in the postoperative phase. Only a few studies investigated the early postoperative changes in cognitive function (< 24 hours) after minor, day case surgeries in older patients (≥65 years), demonstrating a higher incidence than observed ≥1 week after surgery.

Aim of the project: This study aimed to investigate changes in cognitive function after minor surgery in an elderly patient cohort.

It is the effort to plan perioperative care that can reduce the incidence of postoperative cognitive dysfunction in elderly.

Hypothesis: The present study support the hypothesis that changes in cognitive function after ocular surgery will be greater in the general anesthesia group compared to the sedoanalgesia group.

Methods:

The study will be conducted as a single center, prospective, observational controlled trial at the Medical University of Vienna, Austria.

This prospective and observational study involves consecutive elderly patients (≥65 years) undergoing a minor surgery using general anesthesia or local anesthesia with sedoanalgesia. Fifty patients, 65 years and older, scheduled for elective minor ocular surgery and 25 participants as control group without surgical intervention will be recruited.

Enrollees will be divided in 3 groups:

25 patients general anaesthesia (GA), 25 patients sedoanalgesia combined with local anaesthesia (SA) and 25 participants as control group(CO) without surgical intervention.

Anesthesia will be induced in a standardized fashion in both groups (GA,SA). At baseline the performance on neurocognitive testing using the Mini Mental State Examination (MMSE) hast to be ≥24, otherwise participants will be excluded.

The design utilizes prospective serial assessments of cognitive status. The participants will be evaluated preoperatively and postoperatively over 3 time-points (preoperatively, 6 and 24 hours after surgery) using the Neurocognitive Test Battery Vienna (NTBV) for cognitive assessment.

At the same time points blood tests for plasma levels of S 100-B, IL-6, CRP, vitamin B 12, vitamin D, homocysteine and folic acid will be taken.

This project will investigate the correlation between perioperative changes in these serum parameters with neurocognitive outcome in the elderly after minor surgery to explore whether the concentrations of these parameters can be used as predictors of postoperative cognitive dysfunction and to provide reference for postoperative cognitive dysfunction prevention, early detection and timely diagnosis and treatment.

Further purpose of this study is to investigate if there is an association between changes in intraoperative cerebral oxygenation, changes in perioperative blood pressure, depth of anaesthesia and the presence of cognitive deterioration after surgery.

It is the effort to plan perioperative care that can reduce the incidence of postoperative changes in cognitive function.

Study Design

Study Type:
Observational
Anticipated Enrollment :
75 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Early Postoperative Cognitive Impairment in Elderly Patients Following Ocular Surgery
Actual Study Start Date :
Oct 6, 2018
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
General Anesthesia

General anesthesia: 25 patients older than 65 years, undergoing elective eye surgery under general anesthesia. Intervention: neurocognitive testing (Neurocognitive Test Battery) preoperative, 6 and 24 hours postoperative. Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery.

Diagnostic Test: Neurocognitive Test Battery
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.

Diagnostic Test: Blood sampling
Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery, investigating plasma levels of S 100-B, CRP, vitamines, homocysteine and folic acid

Local anesthesia with sedoanalgesia

25 patients older than 65 years, undergoing elective eye surgery under local anesthesia in combination with sedoanalgesia. Intervention: neurocognitive testing (Neurocognitive Test Battery) preoperative, 6 and 24 hours postoperative Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery.

Diagnostic Test: Neurocognitive Test Battery
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.

Diagnostic Test: Blood sampling
Blood sampling before surgery (baseline), immediately postoperative, 6 and 24 hours after surgery, investigating plasma levels of S 100-B, CRP, vitamines, homocysteine and folic acid

Control Group

25 patients, not undergoing any operative intervention. To determine a normal reference value of cognitive functions, a group of 25 individuals without an operative intervention will be recruited as a control group. Intervention: neurocognitive testing (Neurocognitive Test Battery) at 3 determined time points (0, 6 and 24 hours)

Diagnostic Test: Neurocognitive Test Battery
neurocognitive testing: preoperative(baseline), 6 and 24 hours postoperative.

Outcome Measures

Primary Outcome Measures

  1. Neuropsychological Test Battery Vienna (NTBV) [before surgery (baseline) and 24 hours after surgery]

    The Neuropsychological Test Battery Vienna (NTBV) ist a cognitive test to assess a broad range of cognitive abilities.(Lehrner J., 2007) It was created to detect cognitive impairment in Alzheimer's Disease (Lehrner J., 2007). The investigators will investigate changes in NTBV between baseline compared to 24 hour after minor surgery using regression based z-score analyses (-1,5 - + 1,5 standard deviation(SD) ; > -1,5 SD indicating a larger decline in cognitive function).

Secondary Outcome Measures

  1. Neuropsychological Test Battery Vienna (NTBV) [before surgery(baseline) and 6 hours after surgery]

    The Neuropsychological Test Battery Vienna (NTBV) ist a cognitive test. (Lehrner J., 2007)

Other Outcome Measures

  1. Blood sampling- S100b levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of S100-B protein (µg/L) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  2. Blood sampling- IL-6 levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Serum levels of interleukin-6 type cytokines (IL-6 (pg/mL)) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  3. Blood sampling- CRP levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of C-Reactive Protein (CRP) (mg/L)will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  4. Blood sampling- vitamin B12 levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of vitamin B12 (pg/mL) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  5. Blood sampling- vitamin D levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of vitamin D (ng/ml) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  6. Blood sampling- homocysteine levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of homocysteine (mcmol/L)will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

  7. Blood sampling- folic acid levels [before surgery, at the end point of surgery, 6 and 24 hours after surgery]

    Blood sampling will be taken at all patients scheduled for elective ocular surgery. Levels of folic acid (µg/L) will be obtained from venous blood samples collected before surgery, at the end point of surgery, 6 and 24 hours after surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Patients age 65 and older

  2. scheduled to undergo elective ocular surgery

  3. American Society of Anesthesiologists class I, II or III

  4. MMSE score ≥ 24

  5. The people signed informed consent.

  6. Expected surgical duration <90 minutes

  7. Able to follow study instructions.

Exclusion Criteria:
  1. Patients age < 65 years

  2. Emergent nature of the ocular surgery

  3. American Society of Anesthesiologists class IV

  4. MMSE score < 24

  5. unsigned informed consent

  6. Expected surgical duration >90 minutes

  7. Not able to follow study instructions.

  8. History of psychiatric or neurologic disorders (epilepsy, trauma, stroke,depressive disorders, hemorrhage, transient ischemic attack

  9. Drug or substance abuse history

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University Vienna Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marita Windpassinger M.D., Principal Investigator, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT03775343
Other Study ID Numbers:
  • 1907/2017
First Posted:
Dec 13, 2018
Last Update Posted:
Jan 12, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marita Windpassinger M.D., Principal Investigator, Medical University of Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 12, 2022